The deal size was increased to 9.6M shares of common stock from 6.7M shares of common stock. Lake Street acted as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AYTU:
- Aytu BioPharma enters exclusive agreement with Fabre-Kramer Pharmaceuticals
- Aytu BioPharma prices 9.6M shares at $1.50 in upsized public offering
- Aytu BioPharma announces exclusive commercialization agreement for Exxua
- Aytu BioPharma files to sell 6.74M shares of common stock
- Aytu BioScience Holds 2025 Annual Meeting